Thermo Fisher Scientific Inc.
TMO
$605.00
$5.310.89%
NYSE
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.74B | 1.65B | 1.96B | 1.62B | 1.62B |
| Total Depreciation and Amortization | 819.00M | 734.00M | 728.00M | 671.00M | 686.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.00M | -81.00M | 318.00M | 56.00M | -178.00M |
| Change in Net Operating Assets | -425.00M | -1.11B | 447.00M | -104.00M | -726.00M |
| Cash from Operations | 2.13B | 1.19B | 3.46B | 2.24B | 1.40B |
| Capital Expenditure | -450.00M | -376.00M | -465.00M | -404.00M | -294.00M |
| Sale of Property, Plant, and Equipment | 4.00M | 9.00M | 27.00M | 4.00M | 1.00M |
| Cash Acquisitions | 0.00 | -8.87B | 0.00 | -4.04B | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 610.00M | 278.00M | 1.33B | 314.00M | 5.00M |
| Cash from Investing | 164.00M | -8.96B | 891.00M | -4.12B | -288.00M |
| Total Debt Issued | 0.00 | 5.63B | 4.92B | 1.10B | 0.00 |
| Total Debt Repaid | -389.00M | -1.41B | -1.29B | -597.00M | -787.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.00B | -3.00B | -37.00M | -963.00M | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -175.00M | -162.00M | -162.00M | -163.00M | -162.00M |
| Other Financing Activities | -7.00M | 40.00M | 91.00M | -4.00M | -42.00M |
| Cash from Financing | -1.57B | 1.09B | 3.53B | -632.00M | -991.00M |
| Foreign Exchange rate Adjustments | 98.00M | 78.00M | -6.00M | -75.00M | 311.00M |
| Miscellaneous Cash Flow Adjustments | 0.00 | -1.00M | -- | -1.00M | 0.00 |
| Net Change in Cash | 816.00M | -6.60B | 7.87B | -2.59B | 431.00M |